Health Trials

Relapsed/Refractory Small Cell Lung Cancer

2

Review clinical trials related to Relapsed/Refractory Small Cell Lung Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

The purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refractory Small Cell Lung Cancer

Participants needed: 240
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Bristol-Myers SquibbUpdated: Aug 18, 2026Locations: 13
Eligibility criteria

Participants must have histologically or cytologically documented relapsed/refra... [+2]

Participants must not have any untreated CNS metastases. [+3]

Read more
Status: Recruiting

This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

This is a First-in-Human, open-label, early dose-escalation clinical study to evaluate the safety and preliminary efficacy of GC511B CAR T cell injection in Adult with DLL3+ r/r SCLC trial participants.

Participants needed: 55
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesUpdated: May 1, 2026Locations: 2
Eligibility criteria

1.Trial articipant must be ≥ 18 years and ≤75 years of age at the time of signin... [+13]

1.Pregnant or breastfeeding females, or female trial participants with a positiv... [+35]

Read more